Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Share-based Compensation (2019 - 2025)

Historic Share-based Compensation for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $609167.0.

  • Volitionrx's Share-based Compensation rose 8828.24% to $609167.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 5607.12%. This contributed to the annual value of $1.3 million for FY2024, which is 4459.41% down from last year.
  • Per Volitionrx's latest filing, its Share-based Compensation stood at $609167.0 for Q3 2025, which was up 8828.24% from $812045.0 recorded in Q2 2025.
  • Volitionrx's Share-based Compensation's 5-year high stood at $915031.0 during Q1 2022, with a 5-year trough of $208046.0 in Q2 2024.
  • In the last 5 years, Volitionrx's Share-based Compensation had a median value of $555342.0 in 2021 and averaged $551759.9.
  • Per our database at Business Quant, Volitionrx's Share-based Compensation crashed by 6486.74% in 2024 and then soared by 29031.99% in 2025.
  • Quarter analysis of 5 years shows Volitionrx's Share-based Compensation stood at $276729.0 in 2021, then surged by 155.21% to $706249.0 in 2022, then crashed by 34.06% to $465734.0 in 2023, then tumbled by 30.06% to $325738.0 in 2024, then surged by 87.01% to $609167.0 in 2025.
  • Its Share-based Compensation was $609167.0 in Q3 2025, compared to $812045.0 in Q2 2025 and $451374.0 in Q1 2025.